Home/Filings/4/0000950170-23-044843
4//SEC Filing

Essex Woodlands Fund IX-GP, L.P. 4

Accession 0000950170-23-044843

CIK 0001314102other

Filed

Aug 27, 8:00 PM ET

Accepted

Aug 28, 6:32 PM ET

Size

15.3 KB

Accession

0000950170-23-044843

Insider Transaction Report

Form 4
Period: 2023-08-24
Transactions
  • Sale

    Common Stock, $0.001 par value

    2023-08-25$10.67/sh30,000$320,1303,853,760 total(indirect: See footnotes)
  • Sale

    Common Stock, $0.001 par value

    2023-08-24$14.62/sh139,280$2,036,0933,883,760 total(indirect: See footnotes)
  • Sale

    Common Stock, $0.001 par value

    2023-08-25$11.19/sh54,656$611,3493,799,104 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock, $0.001 par value

    2023-08-24$14.62/sh139,280$2,036,0933,883,760 total(indirect: See footnotes)
  • Sale

    Common Stock, $0.001 par value

    2023-08-25$10.67/sh30,000$320,1303,853,760 total(indirect: See footnotes)
  • Sale

    Common Stock, $0.001 par value

    2023-08-25$11.19/sh54,656$611,3493,799,104 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock, $0.001 par value

    2023-08-24$14.62/sh139,280$2,036,0933,883,760 total(indirect: See footnotes)
  • Sale

    Common Stock, $0.001 par value

    2023-08-25$11.19/sh54,656$611,3493,799,104 total(indirect: See footnotes)
  • Sale

    Common Stock, $0.001 par value

    2023-08-25$10.67/sh30,000$320,1303,853,760 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock, $0.001 par value

    2023-08-25$10.67/sh30,000$320,1303,853,760 total(indirect: See footnotes)
  • Sale

    Common Stock, $0.001 par value

    2023-08-24$14.62/sh139,280$2,036,0933,883,760 total(indirect: See footnotes)
  • Sale

    Common Stock, $0.001 par value

    2023-08-25$11.19/sh54,656$611,3493,799,104 total(indirect: See footnotes)
Footnotes (2)
  • [F1]The share totals shown above are the aggregate amounts of shares of Common Stock sold by EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A") on the dates set forth above. EWHP sold 133,890 shares and 81,380 shares of the amounts shown above on August 24, 2023 and August 25, 2023, respectively, and EWHP-A sold 5,390 shares and 3,276 shares of the amounts shown above on August 24, 2023 and August 25, 2023, respectively. EWHP now holds a total of 3,652,177 shares of Common Stock of the Issuer and EWHP-A now holds a total of 146,927 shares of Common Stock of the Issuer.
  • [F2]Essex Woodlands Fund IX-GP, L.P. (the "EW Fund IX GP"), is the general partner of each of EW Healthcare Partners, L.P. ("EWHP") and EW Healthcare Partners-A, L.P. ("EWHP-A" and together with EWHP, the "EWHP Funds"). Essex Woodlands IX, LLC (the "General Partner") is the general partner of EW Fund IX GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Scott Barry, Ron Eastman, Petri Vainio and Steve Wiggins (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Documents

1 file

Issuer

EyePoint Pharmaceuticals, Inc.

CIK 0001314102

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001652285

Filing Metadata

Form type
4
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 6:32 PM ET
Size
15.3 KB